MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia

NCT00545571 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Methoxy polyethylene glycol-epoetin beta

Sponsor

Hoffmann-La Roche